-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
the listing and registration of 1.
2 class 1.
2 Chinese medicine innovative drugs Guangqiancao total flavone capsules.
The main ingredient of the drug is the total flavonoids extracted from Guangqian Herb, and the holder of the drug marketing authorization is Wuhan Guanggu Renfu Biopharmaceutical Co.
, Ltd.
Chinese medicine pharmaceutical companies are using digital technology to promote industrial upgrading (Source: Pharmaceutical Network)
It is understood that in recent years, benefiting from the support of a series of favorable policies, the strategic position of traditional Chinese medicine is constantly improving
.
At the same time, a large number of new Chinese medicine drugs have also begun to be approved
.
In addition to the total flavonoids capsules of Guangqiancao, in August this year, Jianmin Pharmaceutical Group also submitted a clinical application for Tongxing granules, which is a new drug of Chinese medicine class 1.
1; on April 6, Kangyuan Pharmaceutical's traditional Chinese medicine class 1.
1 innovative drug marrow tonic nootropic granules were undertaken; on April 14, Zhengyang Pharmaceutical's Chinese medicine class 1.
1 innovative drug ZY002 gynecological gel was undertaken.
.
.
According to the catalogue of varieties accepted by CDE, from January to March 2022 alone, CDE has undertaken a total of 18 applications for
the registration of new Chinese medicine drugs.
The types of new Chinese medicine drugs applied for are focused on categories 1.
1 and 1.
2, of which 6 are new drugs of class 1.
1
.
.
At the same time, a large number of new Chinese medicine drugs have also begun to be approved
.
In addition to the total flavonoids capsules of Guangqiancao, in August this year, Jianmin Pharmaceutical Group also submitted a clinical application for Tongxing granules, which is a new drug of Chinese medicine class 1.
1; on April 6, Kangyuan Pharmaceutical's traditional Chinese medicine class 1.
1 innovative drug marrow tonic nootropic granules were undertaken; on April 14, Zhengyang Pharmaceutical's Chinese medicine class 1.
1 innovative drug ZY002 gynecological gel was undertaken.
.
.
According to the catalogue of varieties accepted by CDE, from January to March 2022 alone, CDE has undertaken a total of 18 applications for
the registration of new Chinese medicine drugs.
The types of new Chinese medicine drugs applied for are focused on categories 1.
1 and 1.
2, of which 6 are new drugs of class 1.
1
.
From the above point of view, under the background of continuous policy encouragement and support for the development of new Chinese medicine drugs, the vitality and potential of innovation of Chinese medicine enterprises are being continuously released
.
It is worth noting that with the acceleration of the digitization process, as well as the increasing pressure on pharmaceutical companies under the consistency evaluation policies of collection and generic drugs, the rise in labor costs, and the tightening of drug quality supervision, the innovation model of traditional Chinese medicine enterprises is also beginning to undergo profound changes
.
.
It is worth noting that with the acceleration of the digitization process, as well as the increasing pressure on pharmaceutical companies under the consistency evaluation policies of collection and generic drugs, the rise in labor costs, and the tightening of drug quality supervision, the innovation model of traditional Chinese medicine enterprises is also beginning to undergo profound changes
.
It is reported that a large number of enterprises are currently using digital technology to open up the road to
accelerate innovation and transformation.
For example, Tasly is actively embracing digital transformation and has built 2 key laboratories: "State Key Laboratory of Key Technologies of Innovative Chinese Medicine" and "National and Local Joint Engineering Laboratory of Advanced Manufacturing Technology of Chinese Medicine"
.
Relying on the scientific and technological strength of these two laboratories, Tasly has completed the deep integration
of digital technology and traditional Chinese medicine industry.
The intelligent manufacturing system of traditional Chinese medicine with "quality digitalization" as the core has created a new model for the research and development of new Chinese medicine drugs and a new model for intelligent manufacturing for the industrialization of traditional Chinese medicines, and has established a modern intelligent manufacturing system represented by intelligent extraction, pill drops and lyophilized powder injections of traditional Chinese medicines, realizing the digitization and intelligence of the whole process of traditional Chinese medicine production, and making positive contributions to
promoting the high-quality development of traditional Chinese medicine.
accelerate innovation and transformation.
For example, Tasly is actively embracing digital transformation and has built 2 key laboratories: "State Key Laboratory of Key Technologies of Innovative Chinese Medicine" and "National and Local Joint Engineering Laboratory of Advanced Manufacturing Technology of Chinese Medicine"
.
Relying on the scientific and technological strength of these two laboratories, Tasly has completed the deep integration
of digital technology and traditional Chinese medicine industry.
The intelligent manufacturing system of traditional Chinese medicine with "quality digitalization" as the core has created a new model for the research and development of new Chinese medicine drugs and a new model for intelligent manufacturing for the industrialization of traditional Chinese medicines, and has established a modern intelligent manufacturing system represented by intelligent extraction, pill drops and lyophilized powder injections of traditional Chinese medicines, realizing the digitization and intelligence of the whole process of traditional Chinese medicine production, and making positive contributions to
promoting the high-quality development of traditional Chinese medicine.
In the "WIC Intelligent Technology Innovation and Application Excellent Cases" selection activity held at the World Intelligence Conference in June 2022, Tasly "Modern Chinese Medicine Intelligent Manufacturing" was also selected as "WIC Intelligent Technology Innovation and Application Excellent Cases", becoming a model for
accelerating the transformation and application of key technologies of intelligent technology and promoting the intelligent upgrading of industry.
accelerating the transformation and application of key technologies of intelligent technology and promoting the intelligent upgrading of industry.
In addition, CR Sanjiu once mentioned in the research activities that the company has built a digital center and transformed traditional businesses to build new businesses, and has achieved initial results
.
At the same time, the company has also laid out intelligent manufacturing in its digital strategy, connecting the consumer side and the manufacturing end and the front-end traceability
of traditional Chinese medicine.
It expressed its desire to build a mature digital business model
through 2-3 years of hard work.
.
At the same time, the company has also laid out intelligent manufacturing in its digital strategy, connecting the consumer side and the manufacturing end and the front-end traceability
of traditional Chinese medicine.
It expressed its desire to build a mature digital business model
through 2-3 years of hard work.
In addition, Yunnan Baiyao has also created a "Digital 37 Industry Platform" by using 5G, industrial Internet, big data, artificial intelligence, blockchain and other technologies, which can achieve "traceable source, traceable destination, and accountable responsibility", and the whole process of production can be visualized
.
It is worth mentioning that Yunnan Baiyao also said at an investor research conference that it will focus on the "1+4+1" strategy to develop and transform
.
Among them, in terms of digitalization, it is proposed that new technologies, including artificial intelligence, will be introduced into all aspects of R&D and operation, so that development has a higher starting point
.
.
It is worth mentioning that Yunnan Baiyao also said at an investor research conference that it will focus on the "1+4+1" strategy to develop and transform
.
Among them, in terms of digitalization, it is proposed that new technologies, including artificial intelligence, will be introduced into all aspects of R&D and operation, so that development has a higher starting point
.
In general, in the context of digital transformation sweeping the pharmaceutical industry, more and more Chinese medicine companies are accelerating the use of artificial intelligence, big data, electronic data collection and other technologies and platforms to accelerate the efficiency of drug research and development, and further promote the process of clinical trials.
.
.
In this context, the industry expects that with the acceleration of the development of the traditional Chinese medicine industry, major enterprises will continue to deepen the integration and innovation of new technologies and traditional Chinese medicine, so that the traditional industry of traditional Chinese medicine will "bloom new flowers", usher in more innovative achievements, and further promote the high-quality development
of the traditional Chinese medicine industry.
={"common":{"bdSnsKey":{},"bdText":"","bdMini":"1","bdMiniList":false,"bdPic":"","bdStyle":"0","bdSize":"32"},"share":{},"image":{"viewList":[" weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"],"viewText":"Share to:","viewSize:"24"},"selectShare":{" bdContainerClass":null,"bdSelectMiniList":["weixin","sqq","qzone","tsina","tqq","tsohu","tieba","renren","youdao","fx","ty","fbook","twi","copy","print"]}}; with(document)0[(getElementsByTagName('head')[0]|| body). .
.
In this context, the industry expects that with the acceleration of the development of the traditional Chinese medicine industry, major enterprises will continue to deepen the integration and innovation of new technologies and traditional Chinese medicine, so that the traditional industry of traditional Chinese medicine will "bloom new flowers", usher in more innovative achievements, and further promote the high-quality development
of the traditional Chinese medicine industry.
appendChild(createElement('script')).
src='http://bdimg.
share.
baidu.
com/static/api/js/share.
js?v=89860593.
js?cdnversion='+~(-new Date()/36e5)];
